How to Buy Immunovant Stock
Immunovant Inc
Immunovant, Inc. , a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
Immunovant stock last closed at $27.17, down 2.09% from the previous day, and has increased 68.86% in one year. It has overperformed other stocks in the Biotechnology industry by 0.91 percentage points. Immunovant stock is currently +69.81% from its 52-week low of $16.00, and -40.39% from its 52-week high of $45.58.
There are currently 145.29M shares of IMVT outstanding. The market capitalization of IMVT is $3.95B. In the last 24 hours, 1.41M IMVT shares were traded.
How to Buy Immunovant Stock
Not sure how to invest in Immunovant stock? Here's how.
- Choose where to buy Immunovant stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Immunovant stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your investment account: Choose your payment method and add your details.
- Evaluate Immunovant stock: The Immunovant ticker symbol is IMVT. Is Immunovant stock a good investment? Should you buy shares of IMVT? How do IMVT's underlying business fundamentals look? Do top analysts think Immunovant is a good buy? Why has IMVT's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if IMVT is a good stock to buy).
- Make your IMVT trade: Decide if you will purchase IMVT shares at the current market price or use a limit order to buy IMVT stock at a specific price.
- Track your IMVT investment: Create a watchlist to get live updates on your new investment in Immunovant shares.
Step 1: Choose where to buy Immunovant stock
You will need an online brokerage account in order to access the NASDAQ market and buy IMVT stock.
Our preferred brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Technology to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to invest in IMVT today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new brokerage account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've finished signing up on a investment app, your next step is to transfer the money for your investment:
Check out the tutorial below to see the process of depositing money into your investment account.
Step 4: Evaluate Immunovant stock
Once you have decided on the best place to buy Immunovant stock, it's absolutely critical to research their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
Immunovant stock at a glance
Immunovant Zen Score
WallStreetZen was designed to help part-time investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on IMVT's stock page.
Is IMVT stock undervalued?
You can use many financial metrics, analyses, models, and charts to gauge IMVT's fair value.
Using relative valuations methods:
- IMVT may be undervalued based on its P/B ratio of 5.81x, relative to Biotechnology industry P/B ratio of 5.85x
You can do additional valuation analysis on IMVT's stock here.
IMVT Financial Health Overview
Passed Health Checks:
- Total IMVT debt is lower than 5 years ago, relative to shareholder equity.
- IMVT has $690.94M in cash and short term investments. This is sufficient to cover its annual cash burn of $210.56M.
- There are more short-term assets than short-term liabilities on the IMVT balance sheet.
- IMVT has cash burn of 210557000. It has enough cash and short-term investments to cover this for at least one year.
- IMVT has a low debt to equity ratio of 0.05.
- There are more short-term assets than long-term liabilities on the IMVT balance sheet.
Is it a good time to buy IMVT stock, according to analysts?
Out of 9 Equities analysts who give recommendations on IMVT, the consensus analyst rating on Immunovant is a Strong Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent IMVT Analyst Ratings
Jason Gerberry, a top 17% analyst from Bank of America maintains IMVT with a strong buy rating and raises their IMVT price target from $49.00 to $51.00, on Dec 21, 2023.
Bank of America's Jason Gerberry raised their price target on Immunovant (NASDAQ: IMVT) by 4.1% from $49 to $51 on 2023/12/21. The analyst maintained their Strong Buy rating on the stock.
On 2023/12/20, Immunovant announced phase 2 results for batoclimab as a treatment for Graves' disease, the analyst reported.
Although the study was uncontrolled and small, management said it was able to achieve a greater than 50% response rate in patients who are hyperthyroid in spite of treatment with anti-thyroid medication for more than 12 weeks, Gerberry detailed.
Douglas Tsao, a top 14% analyst from HC Wainwright & Co. maintains IMVT with a buy rating and raises their IMVT price target from $47.00 to $51.00, on Dec 21, 2023.
Neena Bitritto-Garg, a top 10% analyst from Deutsche Bank initiates coverage on IMVT with a strong buy rating and announces their IMVT price target of $50.00, on Dec 12, 2023.
Colin Bristow, a bottom 15% analyst from UBS maintains IMVT with a strong buy rating and raises their IMVT price target from $55.00 to $56.00, on Dec 1, 2023.
You can dive deeper into what analysts are saying on the Immunovant stock forecast page.
IMVT Momentum
What are IMVT executives and large shareholders up to?
Over the past 12 months, executives and large shareholders at IMVT have bought more shares than they have sold.
Michael Geffner, Chief Medical Officer of IMVT, was the latest IMVT insider to sell. They sold $94,242.90 worth of IMVT shares on Apr 24, 2024.
Get more info about who owns IMVT stock here.
Can I get consistent income from IMVT stock?
No, Immunovant doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your IMVT trade
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally sufficient. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact dollar amount limit, place a limit order.
Click the Open Trade button and your broker will execute the order.
If you require additional help with buying stocks on eToro, watch the helpful video below:
Step 6: Track your IMVT investment
Now that you own some shares in IMVT, you'll want to keep up with your company.
Start a watchlist to get the latest updates about your IMVT stock.
IMVT Feed
How to Buy Stock in Immunovant
To summarize, here are the 6 steps you need to take to buy Immunovant stock right now:
- Choose where to buy Immunovant stock
- Sign up for your brokerage account
- Put funds into your investment account
- Evaluate Immunovant stock
- Make your IMVT trade
- Track your IMVT investment
If you require a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to monitor your new investment in Immunovant, get started below.
More Articles You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.